Cover Image
市场调查报告书

社交恐惧症:全球临床实验检讨

Social Phobia Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品编码 309952
出版日期 内容信息 英文
订单完成后即时交付
价格
Back to Top
社交恐惧症:全球临床实验检讨 Social Phobia Global Clinical Trials Review, H2, 2014
出版日期: 2014年07月31日 内容信息: 英文
简介

本报告提供社交恐惧症相关的临床研究最新趋势分析,汇整疾病治疗方法概要,及临床实验的主要国家──G7各国及E7(新兴7国)的临床实验数及实验对象采用状况,Phase、阶段别进展,有潜力的赞助商,各企业研究机关的研究进展,有潜力的药剂比较等信息。

目录

简介

  • 社交恐惧症
  • 本报告概要

各地区的临床实验情形

  • 各国临床实验数量和平均实验人数
    • 亚太地区主要5个国家的临床实验数量
    • 欧洲主要5个国家的临床实验数量
    • 北美主要国家的临床实验数量
    • 中东及非洲主要5个国家的临床实验数量
    • 中南美主要5个国家的临床实验数量

G7各国临床实验数量:中枢神经系统临床实验数量上,社交恐惧症临床实验数量所占的比例

G7各国临床实验数量:Phase别

G7各国临床实验数量:各进展状况

Phase别临床实验数量

  • 进行中的临床实验:Phase别

各进展状况临床实验数量

试验指标达成状况别临床实验数量

尚未完成的临床实验数量

一定期间所采用的实验对象

赞助商类别的临床实验数量

有潜力的赞助商

有潜力的药剂

临床实验简介

  • 有代表性的企业临床实验概要
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Eli Lilly and Company
    • Pherin Pharmaceuticals, Inc.
    • Neurocrine Biosciences, Inc.
    • Mylan Inc.
    • Avera Pharmaceuticals, Inc.
    • Apsen Farmaceutica SA
  • 有代表性的研究机关·医院临床实验概要
    • The University of New South Wales
    • National Institute of Mental Health
    • Umea University
    • Massachusetts General Hospital
    • Karolinska Institute
    • University of California, Los Angeles
    • University of South Florida
    • University of Pittsburgh
    • Macquarie University
    • Hamilton Health Sciences

5个有代表性的临床实验简介

附录

图表一览

目录
Product Code: GlobalData

GlobalData's clinical trial report, "Social Phobia Global Clinical Trials Review, H2, 2014" provides data on the Social Phobia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Social Phobia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Social Phobia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Social Phobia
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Social Phobia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Social Phobia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Social Phobia Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Pherin Pharmaceuticals, Inc.
      • Clinical Trial Overview of Pherin Pharmaceuticals, Inc.
      • Neurocrine Biosciences, Inc.
      • Clinical Trial Overview of Neurocrine Biosciences, Inc.
      • Mylan Inc.
      • Clinical Trial Overview of Mylan Inc.
      • Avera Pharmaceuticals, Inc.
      • Clinical Trial Overview of Avera Pharmaceuticals, Inc.
      • Apsen Farmaceutica SA
      • Clinical Trial Overview of Apsen Farmaceutica SA
    • Clinical Trial Overview of Top Institutes / Government
      • The University of New South Wales
      • Clinical Trial Overview of The University of New South Wales
      • National Institute of Mental Health
      • Clinical Trial Overview of National Institute of Mental Health
      • Umea University
      • Clinical Trial Overview of Umea University
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • Karolinska Institute
      • Clinical Trial Overview of Karolinska Institute
      • University of California, Los Angeles
      • Clinical Trial Overview of University of California, Los Angeles
      • University of South Florida
      • Clinical Trial Overview of University of South Florida
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • Macquarie University
      • Clinical Trial Overview of Macquarie University
      • Hamilton Health Sciences
      • Clinical Trial Overview of Hamilton Health Sciences
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Social Phobia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Social Phobia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Social Phobia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Social Phobia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Social Phobia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Social Phobia to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Social Phobia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Social Phobia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Social Phobia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Social Phobia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pherin Pharmaceuticals, Inc., 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurocrine Biosciences, Inc., 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Inc., 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Avera Pharmaceuticals, Inc., 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Apsen Farmaceutica SA, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of New South Wales, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Umea University, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institute, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Macquarie University, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014*

List of Figures

  • Social Phobia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Social Phobia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Social Phobia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Social Phobia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Social Phobia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Social Phobia to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Social Phobia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Social Phobia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Social Phobia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top